BNP Paribas Asset Management’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.51M Buy
394,010
+13,759
+4% +$95.7K ﹤0.01% 1030
2025
Q4
$2.68M Buy
380,251
+379,275
+38,860% +$2.29M ﹤0.01% 1005
2025
Q3
$5K Sell
976
-271
-22% -$1.33K ﹤0.01% 1830
2025
Q2
$6K Buy
+1,247
New +$7.47K ﹤0.01% 1940

Other funds holding LFST

BNP Paribas Asset Management's LFST Position: Q1 2026 in Review

BNP Paribas Asset Management increased its Lifestance Health (LFST) stake by 3.6% in Q1 2026, buying an estimated $95.7K and bringing the position to 394,010 shares worth $2.51M. The position accounts for ﹤0.01% of the portfolio, ranked #1030.

BNP Paribas Asset Management first reported a position in LFST in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.68M in Q4 2025. 229 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • BNP Paribas Asset Management held 394,010 shares of Lifestance Health worth $2.51M as of Q1 2026.
  • BNP Paribas Asset Management bought 13,759 Lifestance Health shares in Q1 2026, an estimated $95.7K.
  • Lifestance Health made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #1030 holding.
  • BNP Paribas Asset Management first reported a position in Lifestance Health in Q2 2025 and has held it in 4 quarters since.
  • BNP Paribas Asset Management's Lifestance Health position peaked at $2.68M in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.